We are live on !
Find out more
Robert Torray Torray Investment Partners
AUM
$741M
Turnover
9.57%
1-Year Est. Return
26.16%
Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.58%
AUM
$682M
AUM Growth
-$16.7M
(-2.4%)
Cap. Flow
-$20.8M
Cap. Flow % of AUM
Cap. Flow %
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
38.28%
Holding
99
New
4
Increased
30
Reduced
38
Closed
11
Avg Time Held
4.5
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Energy
CEG
|
+$22.2M |
| 2 |
Microsoft
MSFT
|
+$18.3M |
| 3 |
Comcast
CMCSA
|
+$16.6M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$4.56M |
| 5 |
Bloom Energy
BE
|
+$4.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$19.5M |
| 2 |
Intuit
INTU
|
+$14.3M |
| 3 |
Phillips 66
PSX
|
+$10.3M |
| 4 |
American Express
AXP
|
+$7.48M |
| 5 |
Copart
CPRT
|
+$6.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Healthcare | 18.7% |
| 3 | Financials | 14.55% |
| 4 | Energy | 11.14% |
| 5 | Miscellaneous | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Royalty Pharma
RPRX
$29B
| $31M | 4.54% |
645,425
-98,930
| -13% | -$4.33M |
2021 Q4
17 quarters
|
|
2
Broadcom
AVGO
$1.64T
| $30.8M | 4.52% |
99,470
+8,333
| +9% | +$2.74M |
2022 Q3
14 quarters
|
|
|
3
Microsoft
MSFT
$3.95T
| $28.8M | 4.22% |
77,732
+43,772
| +129% | +$18.3M |
2016 Q2
39 quarters
|
|
4
Chevron
CVX
$448B
| $27.9M | 4.1% |
135,085
-9,363
| -6% | -$1.71M |
2025 Q2
3 quarters
|
|
|
5
Constellation Energy
CEG
$91.2B
| $25.7M | 3.77% |
92,026
+72,977
| +383% | +$22.2M |
2024 Q4
5 quarters
|
|
|
6
Phillips 66
PSX
$108B
| $25.7M | 3.77% |
141,031
-65,564
| -32% | -$10.3M |
2016 Q2
39 quarters
|
|
7
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$4.67B
| $24.2M | 3.55% |
374,999
+797
| +0.2% | +$48.9K |
2025 Q3
2 quarters
|
|
8
Texas Instruments
TXN
$281B
| $23.5M | 3.45% |
121,157
-18,951
| -14% | -$3.84M |
2022 Q1
16 quarters
|
|
9
Pfizer
PFE
$169B
| $21.8M | 3.2% |
776,455
-27,116
| -3% | -$722K |
2025 Q1
4 quarters
|
|
10
CNA Financial
CNA
$13B
| $21.6M | 3.17% |
470,346
-23,056
| -5% | -$1.09M |
2024 Q3
6 quarters
|
|
11
Oneok
OKE
$60.3B
| $21.6M | 3.16% |
238,682
-21,300
| -8% | -$1.75M |
2025 Q4
1 quarter
|
|
12
PepsiCo
PEP
$181B
| $21.1M | 3.1% |
135,967
+293
| +0.2% | +$45.7K |
2025 Q3
2 quarters
|
|
13
AbbVie
ABBV
$507B
| $20.4M | 2.99% |
93,588
+901
| +1% | +$200K |
2016 Q2
39 quarters
|
|
14
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.11B
| $19.4M | 2.84% |
481,176
+66,774
| +16% | +$3.02M |
2025 Q4
1 quarter
|
|
15
Amgen
AMGN
$242B
| $19M | 2.79% |
54,012
-10,635
| -16% | -$3.79M |
2017 Q3
34 quarters
|
|
16
Blackstone
BX
$93.8B
| $19M | 2.79% |
165,160
+25,613
| +18% | +$3.33M |
2018 Q4
29 quarters
|
|
17
NextEra Energy
NEE
$172B
| $18.5M | 2.72% |
199,478
-35,548
| -15% | -$3.16M |
2025 Q3
2 quarters
|
|
18
Prologis
PLD
$120B
| $17.6M | 2.59% |
133,389
-23,366
| -15% | -$3.12M |
2025 Q1
4 quarters
|
|
19
Marsh
MRSH
$90.2B
| $16.4M | 2.4% |
94,329
-3,348
| -3% | -$602K |
2013 Q2
51 quarters
|
|
|
20
Comcast
CMCSA
$77.6B
| $15.9M | 2.34% |
+555,067
| New | +$16.6M |
2026 Q1
0 quarters
|
|
21
Amazon
AMZN
$2.74T
| $14.9M | 2.19% |
71,778
-642
| -0.9% | -$141K |
2017 Q4
33 quarters
|
|
22
Alphabet (Google) Class A
GOOGL
$3.94T
| $13.3M | 1.96% |
46,370
-908
| -2% | -$285K |
2015 Q3
42 quarters
|
|
23
Apple
AAPL
$5.05T
| $12.6M | 1.85% |
49,566
-495
| -1% | -$129K |
2013 Q2
51 quarters
|
|
24
Casey's General Stores
CASY
$25.7B
| $12.5M | 1.83% |
17,121
-189
| -1% | -$123K |
2024 Q2
7 quarters
|
|
25
JPMorgan Chase
JPM
$893B
| $11.4M | 1.68% |
38,859
| – | – |
2019 Q2
27 quarters
|
|
Similar funds
CC
Robert Torray's Q1 2026 Portfolio in Review
As of Q1 2026, Robert Torray held 99 positions worth $682M, down 2.4% from $698M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Robert Torray withdrew a net $20.8M in Q1 2026, closing 11 positions and reducing 38 holdings. Its most notable exit was UnitedHealth, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Robert Torray opened a new position in Comcast worth $15.9M.
- Robert Torray's largest Q1 2026 buy was Comcast: 555,067 shares worth $15.9M.
- Robert Torray added most to Constellation Energy in Q1 2026, an estimated $22.2M increase.
- Robert Torray's biggest Q1 2026 reduction was Phillips 66, cutting an estimated $10.3M.
- Robert Torray fully exited UnitedHealth in Q1 2026, selling an estimated $19.5M.
- Robert Torray's ten largest holdings make up 38% of its $682M portfolio in Q1 2026.
- Robert Torray opened 4 new positions and closed 11 in Q1 2026.
- Robert Torray's portfolio value fell 2.4% quarter-over-quarter to $682M.
Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.